Patent Assignment
Reel/Frame 059142/0537
Change of Name
Recorded: 2022-02-16
Pages: 4
Assignor
AEGERION PHARMACEUTICALS, INC.
Executed: 2021-03-16
Assignee
AMRYT PHARMACEUTICALS INC.
ONE MAIN STREET, SUITE 800, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Engineered Polypeptides Having Enhanced Duration of Action
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 13, 2021
From: ERICKSON, MARY; LITZINGER, DAVID C.; GHOSH, SOUMITRA S.; GUO, ZIJIAN
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 056234/0019 →
Change of Name
Feb 16, 2022
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 059142/0378 →
Assignment of Assignor's Interest
Feb 16, 2022
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 059142/0420 →
Assignment of Assignor's Interest
Feb 16, 2022
From: AMYLIN PHARMACEUTICALS, LLC; ASTRAZENECA PHARMACEUTICALS LP
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 059142/0541 →
Security Interest
Feb 18, 2022
From: AMRYT PHARMACEUTICALS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 059049/0164 →
Release of Security Interest
Apr 13, 2023
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: AMRYT GENETICS LIMITED; AMRYT PHARMACEUTICALS, INC.; AMRYT ENDO, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 063318/0849 →